Skip to main content

Advertisement

Log in

Posterior reversible encephalopathy syndrome in children with kidney diseases

  • Educational Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Posterior reversible encephalopathy syndrome (PRES) was originally used to describe a reversible, predominantly posterior leukoencephalopathy in patients who had renal insufficiency, hypertension, or who received immunosuppressive therapy. Since PRES is prevalent in children with kidney diseases, awareness and understanding of it is important for practicing pediatric nephrologists. A comprehensive approach to the diagnosis of PRES includes thorough determination of predisposing factors, clinical symptoms, and mandatory appropriate imaging. Unfortunately, the pathophysiology of PRES is still obscure and specificity of radiological examination has not yet been established. Two major predisposing factors, namely hypertension and calcineurin inhibitors, are well recognized. In addition, nephrotic syndrome is a common underlying condition for development of PRES. Frequent symptoms include altered consciousness (coma, stupor, lethargy, confusion), seizure, headache, and visual disturbance. Most of these symptoms usually develop abruptly and resolve within a few weeks after proper management. Cranial magnetic resonance (MR) imaging is the first-line modality of imaging studies for detecting PRES. Diffusion-weighted imaging with quantification of apparent diffusion coefficient (ADC) values by ADC mapping may provide more accurate and specific images in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  PubMed  CAS  Google Scholar 

  2. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M (2008) Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 23:2531–2536

    Article  PubMed  Google Scholar 

  3. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M (2006) Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 48:231–238

    Article  PubMed  Google Scholar 

  4. Ikeda M, Ito S, Hataya H, Honda M, Anbo K (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37:E30

    Article  PubMed  CAS  Google Scholar 

  5. Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 16:537–542

    Article  PubMed  CAS  Google Scholar 

  6. Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK (2003) Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 18:1161–1166

    Article  PubMed  Google Scholar 

  7. Soylu A, Kavukcu S, Turkmen M, Akbas Y (2001) Posterior leukoencephalopathy syndrome in poststreptococcal acute glomerulonephritis. Pediatr Nephrol 16:601–603

    Article  PubMed  CAS  Google Scholar 

  8. Nakahara C, Hasegawa N, Izumi I, Kanemoto K, Iwasaki N (2005) The use of cyclosporine in a boy with a prior episode of posterior encephalopathy. Pediatr Nephrol 20:657–661

    Article  PubMed  Google Scholar 

  9. Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19:859–862

    PubMed  CAS  Google Scholar 

  10. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049

    Article  PubMed  CAS  Google Scholar 

  11. Stott VL, Hurrell MA, Anderson TJ (2005) Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J 35:83–90

    Article  PubMed  CAS  Google Scholar 

  12. Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23:1038–1048

    PubMed  Google Scholar 

  13. Kwon S, Koo J, Lee S (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24:361–364

    Article  PubMed  CAS  Google Scholar 

  14. Lamy C, Oppenheim C, Meder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14:89–96

    PubMed  CAS  Google Scholar 

  15. Crasto SG, Rizzo L, Sardo P, Davini O, De Lucchi R (2004) Reversible encephalopathy syndrome: report of 12 cases with follow-up. Neuroradiology 46:795–804

    Article  PubMed  Google Scholar 

  16. Kinoshita T, Moritani T, Shrier DA, Hiwatashi A, Wang HZ, Numaguchi Y, Westesson PL (2003) Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. Clin Imaging 27:307–315

    Article  PubMed  Google Scholar 

  17. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21:1199–1206

    PubMed  CAS  Google Scholar 

  18. Casey SO, Truwit CL (2000) Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR Am J Neuroradiol 21:243–245

    PubMed  CAS  Google Scholar 

  19. Schwartz RB (2002) Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist 8:22–34

    Article  PubMed  Google Scholar 

  20. Dillon WP, Rowley H (1998) The reversible posterior cerebral edema syndrome. AJNR Am J Neuroradiol 19:591

    PubMed  CAS  Google Scholar 

  21. Pavlakis SG, Frank Y, Chusid R (1999) Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 14:277–281

    Article  PubMed  CAS  Google Scholar 

  22. Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356:411–417

    Article  PubMed  CAS  Google Scholar 

  23. Pula JH, Eggenberger E (2008) Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol 19:479–484

    Article  PubMed  Google Scholar 

  24. Bartynski WS (2008) Posterior reversible encephalopathy syndrome. I. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036–1042

    Article  PubMed  CAS  Google Scholar 

  25. Schiff D, Lopes MB (2005) Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2:303–305

    Article  PubMed  Google Scholar 

  26. Singh N, Bonham A, Fukui M (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69:467–472

    Article  PubMed  CAS  Google Scholar 

  27. Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346

    Article  PubMed  CAS  Google Scholar 

  28. Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13:313–326

    Article  PubMed  CAS  Google Scholar 

  29. Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y, Mizoue T, Kiya K, Tanaka I (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19:442–444

    Article  PubMed  Google Scholar 

  30. Wright RR, Mathews KD (1996) Hypertensive encephalopathy in childhood. J Child Neurol 11:193–196

    Article  PubMed  CAS  Google Scholar 

  31. Punaro M, Abou-Jaoude P, Cimaz R, Ranchin B (2007) Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus 16:576–579

    Article  PubMed  CAS  Google Scholar 

  32. Won SC, Kwon SY, Han JW, Choi SY, Lyu CJ (2009) Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 31:505–508

    Article  PubMed  Google Scholar 

  33. Lai CC, Chen SJ, Lien SH, Lo CP, Cheng SN (2008) Posterior reversible encephalopathy in a child with Langerhans cell histiocytosis following allogeneic PBSCT treatment with cyclosporine. Eur J Pediatr 167:817–820

    Article  PubMed  CAS  Google Scholar 

  34. Kanekiyo T, Hara J, Matsuda-Hashii Y, Fujisaki H, Tokimasa S, Sawada A, Kubota K, Shimono K, Imai K, Ozono K (2005) Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int J Hematol 81:264–268

    Article  PubMed  CAS  Google Scholar 

  35. Bohlin AB, Berg U, Englund M, Malm G, Persson A, Tibell A, Tyden G (1990) Central nervous system complications in children treated with ciclosporin after renal transplantation. Child Nephrol Urol 10:225–230

    PubMed  CAS  Google Scholar 

  36. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165:627–631

    PubMed  CAS  Google Scholar 

  37. Magnasco A, Rossi A, Catarsi P, Gusmano R, Ginevri F, Perfumo F, Ghiggeri GM (2008) Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives. Curr Clin Pharmacol 3:166–173

    Article  PubMed  CAS  Google Scholar 

  38. Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RB Jr (1996) Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 166:683–688

    PubMed  CAS  Google Scholar 

  39. Doucet A, Favre G, Deschenes G (2007) Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol 22:1983–1990

    Article  PubMed  Google Scholar 

  40. Becquet O, Pasche J, Gatti H, Chenel C, Abely M, Morville P, Pietrement C (2010) Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol 25:275–280

    Article  PubMed  Google Scholar 

  41. Gomez-Lado C, Martinon-Torres F, Alvarez-Moreno A, Eiris-Punal J, Carreira-Sande N, Rodriguez-Nunez A, Castro-Gago M (2007) Reversible posterior leukoencephalopathy syndrome: an infrequent complication in the course of haemolytic-uremic syndrome. Rev Neurol 44:475–478

    PubMed  CAS  Google Scholar 

  42. Zhang YX, Liu JR, Ding MP, Huang J, Zhang M, Jansen O, Deuschl G, Eschenfelder CC (2008) Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis. Intern Med 47:867–875

    Article  PubMed  Google Scholar 

  43. Ozcakar ZB, Ekim M, Fitoz S, Teber S, Hizel S, Acar B, Yuksel S, Yalcinkaya F (2004) Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 163:728–730

    Article  PubMed  Google Scholar 

  44. De Laat P, Te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472–478

    Article  PubMed  Google Scholar 

  45. Sanchez-Carteyron A, Alarcia R, Ara JR, Martin J (2010) Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology 74:1471–1473

    Article  PubMed  Google Scholar 

  46. Ong B, Bergin P, Heffernan T, Stuckey S (2009) Transient seizure-related MRI abnormalities. J Neuroimaging 19:301–310

    Article  PubMed  Google Scholar 

  47. Doelken M, Lanz S, Rennert J, Alibek S, Richter G, Doerfler A (2007) Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 13:125–128

    PubMed  Google Scholar 

  48. Benziada-Boudour A, Schmitt E, Kremer S, Foscolo S, Riviere AS, Tisserand M, Boudour A, Bracard S (2009) Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol 36:102–105

    Article  PubMed  CAS  Google Scholar 

  49. Ishikura K, Hamasaki Y, Sakai T, Hataya H, Goto T, Miyama S, Kono T, Honda M (2010) Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient. Clin Exp Nephrol. doi:10.1007/s10157-010-0380-2

    PubMed  Google Scholar 

  50. Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, Tortora F, Striano S, Tufano R (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33:230–236

    Article  PubMed  Google Scholar 

  51. Bartynski WS, Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29:447–455

    Article  PubMed  CAS  Google Scholar 

  52. Bartynski WS, Boardman JF (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28:1320–1327

    Article  PubMed  CAS  Google Scholar 

  53. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432

    Article  PubMed  Google Scholar 

  54. Epker JL, van Biezen P, van Daele PL, van Gelder T, Vossen A, van Saase JL (2009) Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states. Eur J Intern Med 20:261–267

    Article  PubMed  CAS  Google Scholar 

  55. Paues J, Vrethem M (2010) Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab. J Clin Virol 48:291–293

    Article  PubMed  Google Scholar 

  56. Kumar D (2010) Emerging viruses in transplantation. Curr Opin Infect Dis 23:374–378

    PubMed  Google Scholar 

  57. Yoon JH, Bang OY, Kim HS (2007) Progressive multifocal leukoencephalopathy in AIDS: proton MR spectroscopy patterns of asynchronous lesions confirmed by serial diffusion-weighted imaging and apparent diffusion coefficient mapping. J Clin Neurol 3:200–203

    Article  PubMed  Google Scholar 

  58. Ko MW, Liu GT (2010) Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr 74:381–389

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Shuichi Ito, Dr. Tatsuo Kono, Dr. Tomohide Goto, and Dr. Sahoko Miyama who provided generous advice in preparing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Ishikura.

Additional information

Answers

1. e

2. b

3. b

4. e

5. c

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishikura, K., Hamasaki, Y., Sakai, T. et al. Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 27, 375–384 (2012). https://doi.org/10.1007/s00467-011-1873-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-1873-2

Keywords

Navigation